These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Nitro seco analogues of the duocarmycins containing sulfonate leaving groups as hypoxia-activated prodrugs for cancer therapy. Stevenson RJ; Denny WA; Tercel M; Pruijn FB; Ashoorzadeh A J Med Chem; 2012 Mar; 55(6):2780-802. PubMed ID: 22339090 [TBL] [Abstract][Full Text] [Related]
12. Cytotoxic palladium complexes of bioreductive quinoxaline N1,N4-dioxide prodrugs. Urquiola C; Vieites M; Torre MH; Cabrera M; Lavaggi ML; Cerecetto H; González M; Cerain AL; Monge A; Smircich P; Garat B; Gambino D Bioorg Med Chem; 2009 Feb; 17(4):1623-9. PubMed ID: 19162490 [TBL] [Abstract][Full Text] [Related]
13. The production of hydroxyl radical from copper(I) complex systems of bleomycin and tallysomycin: comparison with copper(II) and iron(II) systems. Sugiura Y Biochem Biophys Res Commun; 1979 Sep; 90(1):375-83. PubMed ID: 91372 [No Abstract] [Full Text] [Related]
14. Prodrugs for targeting hypoxic tissues: regiospecific elimination of aspirin from reduced indolequinones. Jaffar M; Everett SA; Naylor MA; Moore SG; Ulhaq S; Patel KB; Stratford MR; Nolan J; Wardman P; Stratford IJ Bioorg Med Chem Lett; 1999 Jan; 9(1):113-8. PubMed ID: 9990467 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of cyclic and acyclic nitrobenzylphosphoramide mustards for E. coli nitroreductase activation. Jiang Y; Han J; Yu C; Vass SO; Searle PF; Browne P; Knox RJ; Hu L J Med Chem; 2006 Jul; 49(14):4333-43. PubMed ID: 16821793 [TBL] [Abstract][Full Text] [Related]
16. Hypoxia-activated prodrugs: substituent effects on the properties of nitro seco-1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-one (nitroCBI) prodrugs of DNA minor groove alkylating agents. Tercel M; Atwell GJ; Yang S; Stevenson RJ; Botting KJ; Boyd M; Smith E; Anderson RF; Denny WA; Wilson WR; Pruijn FB J Med Chem; 2009 Nov; 52(22):7258-72. PubMed ID: 19877646 [TBL] [Abstract][Full Text] [Related]
17. Interaction of p-phenylenediamine with the iron-bleomycin complex. Løvstad RA Biometals; 1999 Sep; 12(3):233-6. PubMed ID: 10581686 [TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationships for 4-nitrobenzyl carbamates of 5-aminobenz[e]indoline minor groove alkylating agents as prodrugs for GDEPT in conjunction with E. coli nitroreductase. Hay MP; Atwell GJ; Wilson WR; Pullen SM; Denny WA J Med Chem; 2003 Jun; 46(12):2456-66. PubMed ID: 12773049 [TBL] [Abstract][Full Text] [Related]
20. Targeting the delivery of glycan-based paclitaxel prodrugs to cancer cells via glucose transporters. Lin YS; Tungpradit R; Sinchaikul S; An FM; Liu DZ; Phutrakul S; Chen ST J Med Chem; 2008 Dec; 51(23):7428-41. PubMed ID: 19053781 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]